ERIS Lifescience

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE406M01024
NSEID: ERIS
BSEID: 540596

INR

1,574.70

-17.75 (-1.11%)

BSENSE

Dec 12

BSE+NSE Vol: 1.04 lacs

{
  "main_header": {
    "sid": 1002771,
    "name": "ERIS Lifescience",
    "stock_name": "ERIS Lifescience",
    "full_name": "ERIS Lifesciences Ltd",
    "name_url": "stocks-analysis/eris-lifescience",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,574.70",
    "chg": -17.75,
    "chgp": "-1.11%",
    "dir": -1,
    "prev_price": "1,592.45",
    "mcapval": "21,540.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 540596,
    "symbol": "ERIS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE406M01024",
    "curr_date": "Dec 12",
    "curr_time": "",
    "bse_nse_vol": "1.04 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 12, 2025",
    "traded_date_str": "2025 12 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/eris-lifescience-1002771-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "ERIS Lifesciences Exhibits Shift in Price Momentum Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/eris-lifesciences-shows-mixed-technical-signals-amid-price-momentum-shift-3754776",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ERISLifescience_technicaldot_3754776.png",
        "date": "2025-12-10 08:12:21",
        "description": "ERIS Lifesciences has demonstrated a notable shift in its price momentum, transitioning from a sideways trend to a mildly bullish stance. This movement is underscored by a complex interplay of technical indicators, including moving averages, MACD, RSI, and Bollinger Bands, which collectively paint a nuanced picture of the stock’s current market dynamics within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is ERIS Lifescience falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-eris-lifescience-fallingrising-3754431",
        "imagepath": "",
        "date": "2025-12-10 00:45:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Strong Price Performance Against Benchmarks</strong></p>\n<p>ERIS Lifescience's recent price movement stands out distinctly when compared to broader market indices. Over the past week, the stock appreciated by 7.93%, while the Sensex declined by 0.55%. This outperformance extends over longer periods as well, with the stock delivering a 24.30% gain year-to-date against the Sensex's 8.35%. Even on a three-year horizon, ERIS Lifescience has generated an impressive 151.13% return, vastly outpacing the benchmark's 36.16%. Such consistent outperformance underscores the stock's resilience and growing investor confidence.</p>\n<p><strong>Technical Indicators Signal Positive Momentum</strong></p>\n<p>On the day of the rally, the stock reversed a ten-day losing streak, touching an intraday high of ₹1,737..."
      },
      {
        "title": "ERIS Lifesciences Hits Intraday High with Strong 7.5% Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/eris-lifesciences-hits-intraday-high-with-7-surge-on-9-dec-2025-3753966",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ERISLifescience_priceRelatedfactors_3753966.png",
        "date": "2025-12-09 13:37:39",
        "description": "ERIS Lifesciences demonstrated robust intraday performance on 9 December 2025, reaching a day’s high of Rs 1,652.65, reflecting a 7.54% rise. This surge marked a notable reversal after a ten-day period of consecutive declines, positioning the stock well above key short-term moving averages despite broader market softness."
      },
      {
        "title": "Is ERIS Lifescience technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-eris-lifescience-technically-bullish-or-bearish-3740817",
        "imagepath": "",
        "date": "2025-12-02 09:41:23",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Technical Trend Shift</strong></p>\n<p>After a period of mild bullishness, ERIS Lifescience’s technical trend has transitioned to a sideways movement. This change suggests a phase of consolidation where neither buyers nor sellers dominate decisively. Such a pattern often indicates market indecision, with the stock price oscillating within a range rather than trending strongly upwards or downwards.</p>\n<p>The current price stands at ₹1,582.80, slightly below the previous close of ₹1,595.30. The stock’s 52-week high is ₹1,909.55, while the low is ₹1,130.05, indicating a significant range of price movement over the past year. Today’s trading range has been relatively narrow, with a high of ₹1,595.90 and a low of ₹1,575.00, reinforcing the sideways momentum.</p>\n<p><strong>Key Technical In..."
      },
      {
        "title": "ERIS Lifesciences Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/eris-lifesciences-faces-technical-momentum-shift-amid-mixed-indicator-signals-3740311",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ERISLifescience_technicaldot_3740311.png",
        "date": "2025-12-02 08:11:00",
        "description": "ERIS Lifesciences has experienced a notable shift in its technical momentum, moving from a mildly bullish trend to a sideways pattern. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, and moving averages, reflecting a nuanced market assessment for the pharmaceutical and biotechnology company."
      },
      {
        "title": "ERIS Lifescience Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marketsmojo-downgrades-eris-lifescience-from-buy-to-hold-amid-valuation-concerns-3733045",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ERISLifescience_mojoScore_3733045.png",
        "date": "2025-11-27 10:06:45",
        "description": "ERIS Lifescience has undergone a revision in its market evaluation, reflecting a nuanced shift in its financial and technical outlook. The pharmaceutical and biotechnology company’s recent assessment highlights a blend of strong operational metrics alongside valuation concerns, prompting a reassessment of its investment appeal."
      },
      {
        "title": "Why is ERIS Lifescience falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-eris-lifescience-fallingrising-3716416",
        "imagepath": "",
        "date": "2025-11-19 23:24:03",
        "description": "As of 19-Nov, ERIS Lifesciences Ltd is experiencing a price increase, currently at Rs 1,608.00, reflecting a rise of Rs 34.0 or 2.16%. The stock has shown strong performance today, outperforming its sector by 2.09% and achieving a consecutive gain over the last four days, with a total return of 6.04% during this period. Additionally, the stock has demonstrated impressive returns over various time frames, including a 17.47% increase year-to-date and a substantial 137.62% rise over the past three years. The company's high management efficiency, as indicated by a return on capital employed (ROCE) of 16.70%, and a low debt to EBITDA ratio of 1.32 times, further support its positive outlook. Moreover, the company has reported positive results for the last three consecutive quarters, contributing to investor confidence.\n\nIn the broader market context, the stock's short-term return of 2.17% over the past week sign..."
      },
      {
        "title": "Is ERIS Lifescience technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-eris-lifescience-technically-bullish-or-bearish-3706004",
        "imagepath": "",
        "date": "2025-11-17 08:08:54",
        "description": "As of 14 November 2025, the technical trend for ERIS Lifescience has changed from sideways to mildly bullish. The current stance is mildly bullish, driven primarily by the daily moving averages indicating bullish momentum. However, the weekly MACD and KST remain mildly bearish, suggesting some caution in the short term. The monthly MACD is bullish, providing a stronger long-term outlook. The Bollinger Bands show a mixed signal with a bearish weekly stance and a mildly bullish monthly view. Overall, while there are bullish indicators, the presence of bearish signals in the weekly timeframe indicates a cautious approach is warranted...."
      },
      {
        "title": "Eris Lifesciences Shows Mixed Technical Trends Amid Strong Long-Term Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/eris-lifesciences-technical-trend-shifts-from-sideways-to-mildly-bullish-amid-strong-performance-3706351",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ERISLifescience_technicaldot_3706351.png",
        "date": "2025-11-17 08:03:52",
        "description": "Eris Lifesciences, a small-cap pharmaceutical company, has recently revised its evaluation amid changing market conditions. The stock has shown strong performance over the past year, significantly outperforming the Sensex. Technical indicators present a mixed outlook, reflecting varying trends on weekly and monthly bases. Long-term returns remain impressive."
      }
    ],
    "total": 275,
    "sid": "1002771",
    "stock_news_url": "https://www.marketsmojo.com/news/eris-lifesciences-1002771"
  },
  "announcements": [
    {
      "caption": "Clarification sought from Eris Lifesciences Ltd",
      "datetime": "10-Dec-2025",
      "details": "The Exchange has sought clarification from Eris Lifesciences Ltd on December 10 2025 with reference to Movement in Volume.<BR><BR>The reply is awaited.",
      "source": "BSE"
    },
    {
      "caption": "Clarification With Respect To Increase In Volume",
      "datetime": "10-Dec-2025",
      "details": "as attached",
      "source": "BSE"
    },
    {
      "caption": "Corrigendum To The Notice Of Postal Ballot Dated November 24 2025",
      "datetime": "05-Dec-2025",
      "details": "as attached",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "ERIS Lifesciences Ltd has declared <strong>735%</strong> dividend, ex-date: 13 Feb 25",
          "dt": "2025-02-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

ERIS Lifesciences Exhibits Shift in Price Momentum Amid Mixed Technical Signals

2025-12-10 08:12:21

ERIS Lifesciences has demonstrated a notable shift in its price momentum, transitioning from a sideways trend to a mildly bullish stance. This movement is underscored by a complex interplay of technical indicators, including moving averages, MACD, RSI, and Bollinger Bands, which collectively paint a nuanced picture of the stock’s current market dynamics within the Pharmaceuticals & Biotechnology sector.

Why is ERIS Lifescience falling/rising?

2025-12-10 00:45:46

Strong Price Performance Against Benchmarks

ERIS Lifescience's recent price movement stands out distinctly when compared to broader market indices. Over the past week, the stock appreciated by 7.93%, while the Sensex declined by 0.55%. This outperformance extends over longer periods as well, with the stock delivering a 24.30% gain year-to-date against the Sensex's 8.35%. Even on a three-year horizon, ERIS Lifescience has generated an impressive 151.13% return, vastly outpacing the benchmark's 36.16%. Such consistent outperformance underscores the stock's resilience and growing investor confidence.

Technical Indicators Signal Positive Momentum

On the day of the rally, the stock reversed a ten-day losing streak, touching an intraday high of ₹1,737...

ERIS Lifesciences Hits Intraday High with Strong 7.5% Surge

2025-12-09 13:37:39

ERIS Lifesciences demonstrated robust intraday performance on 9 December 2025, reaching a day’s high of Rs 1,652.65, reflecting a 7.54% rise. This surge marked a notable reversal after a ten-day period of consecutive declines, positioning the stock well above key short-term moving averages despite broader market softness.

Is ERIS Lifescience technically bullish or bearish?

2025-12-02 09:41:23

Recent Technical Trend Shift

After a period of mild bullishness, ERIS Lifescience’s technical trend has transitioned to a sideways movement. This change suggests a phase of consolidation where neither buyers nor sellers dominate decisively. Such a pattern often indicates market indecision, with the stock price oscillating within a range rather than trending strongly upwards or downwards.

The current price stands at ₹1,582.80, slightly below the previous close of ₹1,595.30. The stock’s 52-week high is ₹1,909.55, while the low is ₹1,130.05, indicating a significant range of price movement over the past year. Today’s trading range has been relatively narrow, with a high of ₹1,595.90 and a low of ₹1,575.00, reinforcing the sideways momentum.

Key Technical In...

Read More

ERIS Lifesciences Technical Momentum Shifts Amid Mixed Market Signals
2025-12-02 08:11:00
ERIS Lifesciences has experienced a notable shift in its technical momentum, moving from a mildly bullish trend to a sideways pattern. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, and moving averages, reflecting a nuanced market assessment for the pharmaceutical and biotechnology company.
Read More

ERIS Lifescience Sees Revision in Market Evaluation Amid Mixed Financial Signals
2025-11-27 10:06:45
ERIS Lifescience has undergone a revision in its market evaluation, reflecting a nuanced shift in its financial and technical outlook. The pharmaceutical and biotechnology company’s recent assessment highlights a blend of strong operational metrics alongside valuation concerns, prompting a reassessment of its investment appeal.
Read More

Why is ERIS Lifescience falling/rising?
2025-11-19 23:24:03
As of 19-Nov, ERIS Lifesciences Ltd is experiencing a price increase, currently at Rs 1,608.00, reflecting a rise of Rs 34.0 or 2.16%. The stock has shown strong performance today, outperforming its sector by 2.09% and achieving a consecutive gain over the last four days, with a total return of 6.04% during this period. Additionally, the stock has demonstrated impressive returns over various time frames, including a 17.47% increase year-to-date and a substantial 137.62% rise over the past three years. The company's high management efficiency, as indicated by a return on capital employed (ROCE) of 16.70%, and a low debt to EBITDA ratio of 1.32 times, further support its positive outlook. Moreover, the company has reported positive results for the last three consecutive quarters, contributing to investor confidence. In the broader market context, the stock's short-term return of 2.17% over the past week sign...
Read More

Is ERIS Lifescience technically bullish or bearish?
2025-11-17 08:08:54
As of 14 November 2025, the technical trend for ERIS Lifescience has changed from sideways to mildly bullish. The current stance is mildly bullish, driven primarily by the daily moving averages indicating bullish momentum. However, the weekly MACD and KST remain mildly bearish, suggesting some caution in the short term. The monthly MACD is bullish, providing a stronger long-term outlook. The Bollinger Bands show a mixed signal with a bearish weekly stance and a mildly bullish monthly view. Overall, while there are bullish indicators, the presence of bearish signals in the weekly timeframe indicates a cautious approach is warranted....
Read More

Eris Lifesciences Shows Mixed Technical Trends Amid Strong Long-Term Performance
2025-11-17 08:03:52
Eris Lifesciences, a small-cap pharmaceutical company, has recently revised its evaluation amid changing market conditions. The stock has shown strong performance over the past year, significantly outperforming the Sensex. Technical indicators present a mixed outlook, reflecting varying trends on weekly and monthly bases. Long-term returns remain impressive.
Read More